I am interested in other institutions' guidelines, protocols, policies, etc. for bivalirudin, especially for pediatric use. Would anyone have something to share?

I am interested in other institutions' guidelines, protocols, policies, etc. for bivalirudin, especially for pediatric use. Would anyone have something to share?

Hello All-

Our Healthcare system is in the process of evaluating insulin pen vs. vial for the short-acting, long acting insulin.

What does everyone use at their sites?

Natalie Zilban, PharmD, MPH, BCGP
Pharmacy Safety and Medication Officer
Memorial Healthcare System
Ft. Lauderdale, FL 33311

Greetings! I am hoping to connect with organizations/facilities that serve the oncology population and have successfully eliminated injectable promethazine. The biggest area of concern/debate among some of our facilities is treatment of breakthrough nausea/vomiting in the oncology population.

I appreciate any information/pearls in this area others are willing to share. Also if you have a subject matter expert that would be willing to be contacted briefly by our team that would be appreciated!

Are patients required to be in negative pressure rooms for tobi nebs? Are there any other precautions around the administration of tobi nebs for inpatients at your facilities?

I am in communication with our system's respiratory council regarding a concern with sterile water for inhalation provided in flexible IV bags and the potential for incorrect IV administration as they appear very similar to standard IV bags. The product is used to provide humidification for a number of respiratory devices from the CareFusion AirLife line. Does anyone else have any experience with this product? Were any measures taken to distinguish the product from IV infusion therapies? Thanks

Has anyone completed a FMEA on the Box Picker or similar inventory management system that would share the findings? Much appreciated.

We are currently working on developing a downtime procedures for if/when our ADC (Pyxis) fails. If anyone is willing to share we would be greatful.
Thank you

Terrence Davidson BSP
Medication Safety Resource Pharmacist - Pharmacy Department
Royal University Hospital – Saskatoon Saskatchewan Canada
Saskatchewan Health Authority | 306-655-2274

We are focusing work in our ADC override rates and practices.

I wanted to verify how organizations were calculating their ADC override %s for metrics:

• # overrides / all ADC med vends or
• # overrides / all ADC vends for only meds that can be overridden

In creating tableau drilldowns by medication, I wanted to verify the denominator systems are using.

Thank you for weighing in!

Hi Everyone,

Is anyone willing to share their policies on a/b and ethanol locks? At our hospital, the CLABSI rate is increasing and we are reviewing if anyone is using a/b or ethanol locks different/prophylaxis for pts with documented central line infections. If you want you can post policy or protocols on discussion board or email pananthasingam@blythedale.org. Thank You for you help.